Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study to Evaluate the Effect and Safety of the Use of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

NCT06363201 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT06363201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06363201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study to Evaluate the Effect and Safety of the Use of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours
Lead sponsor
Catalysis SL
Phase
Not applicable
Overall status
Unknown status
Start date
April 28, 2024
Completion date
December 15, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, advanced solid tumor, central nervous system tumor, germ cell tumor, lymphoma, hodgkin, pediatric cancer, sarcoma